BCAL Diagnostics (ASX: BDX)
We spoke to Jayne Shaw, Executive Chair of BCAL Diagnostics (ASX: BDX) about the competitive advantage of the company’s blood test for breast cancer and its new tests for pancreatic and ovarian cancer.
BCAL’s blood test helps detect cancers where mammography is unclear due to high breast density. The clinical data is good and the company is going after further reimbursement.
Looking for the Best ASX Life Sciences stocks to invest in right now?
